Salivary Gland Tumors

Neutron therapy is appropriate for the following histologies:

• Squamous cell carcinoma
• Adenoid cystic carcinoma
• Mucoepidermoid carcinoma
• Not otherwise specified adenocarcinoma
• Malignant mixed tumor
• Aggressive benign mixed tumor
• Aggressive benign fibroxanthoma
• Pleomorphic adenoma
• Acinic Cell Carcinona

Patients who may benefit from neutron therapy include:

• Newly diagnosed patients with unresectable (inoperable) disease, or residual disease following surgery (positive margins).
• Patients whose disease has recurred after surgery and/or radiation.
• Patients who have no gross residual disease following surgery but are considered at risk for recurrence.